60 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
Fast Track designation, the market size for the Company’s product candidates to be smaller than anticipated, clinical trial sites, supply chain
8-K
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
, the market size for the Company’s product candidates to be smaller than anticipated, clinical trial sites, supply chain and manufacturing facilities
8-K
EX-99.1
STRO
Sutro Biopharma Inc
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
leverage Fast Track designation, the market size for the Company’s product candidates to be smaller than anticipated, clinical trial sites, supply … chain and manufacturing facilities, the Company’s ability to maintain and recognize the benefits of certain designations received by product candidates
424B5
STRO
Sutro Biopharma Inc
9 Feb 24
Prospectus supplement for primary offering
4:25pm
candidates to be smaller than anticipated, clinical trial sites, supply chain and manufacturing facilities, the Company’s ability to maintain and recognize
8-K
lv2zc 94mtk3oanz
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
ku8hmqb4j6m 3n
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
7inod7bmik6u7wunp
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
pn0g2w2kdgv5ev67qhe
10 Aug 23
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
EX-99.1
bbh7jq39sz99dp ea
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
8-K
EX-99.1
cu5qgt
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm
8-K
EX-99.1
lq3p13v8
8 Nov 22
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
EX-99.1
tro8u
8 Aug 22
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
4:32pm